Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $103.2600 (-0.02%) ($102.6000 - $103.3900) on Thu. Dec. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.76% (three month average) | RSI | 37 | Latest Price | $103.2600(-0.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(45%) SPLV(36%) VYM(33%) XLP(33%) DIA(32%) | Factors Impacting ABBV price | ABBV will decline at least -0.88% in a week (0% probabilities). VIXM(-23%) UUP(-10%) VXX(-5%) IGOV(-2%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.88% (StdDev 1.76%) | Hourly BBV | -2.4 () | Intraday Trend | 0.1% | | | |
|
Resistance Level | $104.99 | 5 Day Moving Average | $103.5(-0.23%) | 10 Day Moving Average | $104(-0.71%) | 20 Day Moving Average | $104.99(-1.65%) | To recent high | -5% | To recent low | 28.3% | Market Cap | $182.18b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |